Report: FDA underfunded, understaffed

An FDA advisory committee has joined the chorus lamenting an underfunded, understaffed regulatory agency. Released Friday, the report not only castigates the FDA for its woeful understanding of current science, but said its staffing is inadequate for the job and its IT systems are obsolete, and therefore completely ineffective.

Believe it or not, FDA inspectors hand-write their reports. Other dangerous-product reports aren't analyzed or compared fast enough. And the agency doesn't have backup systems, so data gets lost in system crashes.

What would fix the problem? Doubling the agency's budget, for starters. Consumers pay 1.5 cents per day to operate the FDA, the report states, and 3 cents a day wouldn't be too much to ask.

- see this release on the findings
- read the report from USA Today

Related Articles:
FDA badly needs more money, staff. Report
The FDA: Caught between a rock and a hard place. Report
FDA can't guarantee drug safety. Report
Overseas drugmaking goes unsupervised. Report
Poll finds problems at the FDA. Report

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.